Shanghai - Delayed Quote CNY

Guangxi LiuYao Group Co., Ltd (603368.SS)

Compare
15.05 -0.17 (-1.12%)
At close: September 9 at 3:00 PM GMT+8
Loading Chart for 603368.SS
DELL
  • Previous Close 15.22
  • Open 15.11
  • Bid 15.04 x --
  • Ask 15.05 x --
  • Day's Range 14.92 - 15.22
  • 52 Week Range 14.92 - 24.10
  • Volume 6,210,958
  • Avg. Volume 6,123,222
  • Market Cap (intraday) 6.005B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 6.35
  • EPS (TTM) 2.37
  • Earnings Date --
  • Forward Dividend & Yield 0.60 (3.99%)
  • Ex-Dividend Date Jun 11, 2024
  • 1y Target Est 31.29

Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China. It also offers smart medicine value-added services. The company was founded in 1981 and is based in Liuzhou, China.

web.lzyy.cn

5,582

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 603368.SS

View More

Performance Overview: 603368.SS

Trailing total returns as of 9/9/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

603368.SS
18.13%
SSE Composite Index
8.02%

1-Year Return

603368.SS
23.17%
SSE Composite Index
12.20%

3-Year Return

603368.SS
3.41%
SSE Composite Index
25.54%

5-Year Return

603368.SS
35.56%
SSE Composite Index
8.77%

Compare To: 603368.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 603368.SS

View More

Valuation Measures

Annual
As of 9/9/2024
  • Market Cap

    6.01B

  • Enterprise Value

    7.66B

  • Trailing P/E

    6.35

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.26

  • Price/Book (mrq)

    0.80

  • Enterprise Value/Revenue

    0.36

  • Enterprise Value/EBITDA

    5.48

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.13%

  • Return on Assets (ttm)

    3.95%

  • Return on Equity (ttm)

    12.63%

  • Revenue (ttm)

    21.11B

  • Net Income Avi to Common (ttm)

    870.81M

  • Diluted EPS (ttm)

    2.37

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.23B

  • Total Debt/Equity (mrq)

    60.99%

  • Levered Free Cash Flow (ttm)

    -1.56B

Research Analysis: 603368.SS

View More

Company Insights: 603368.SS

Research Reports: 603368.SS

View More

People Also Watch